Fluzone High-dose Quadrivalent: no new safety concerns in US

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1890卷 / 1期
关键词：
D O I：
10.1007/s40278-022-09005-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：8 / 8
相关论文
共 50 条
  • [31] Safety aspects of incobotulinumtoxinA high-dose therapy
    Dirk Dressler
    Fereshte Adib Saberi
    Katja Kollewe
    Christoph Schrader
    Journal of Neural Transmission, 2015, 122 : 327 - 333
  • [32] High-Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults
    Palmu, Arto A.
    Pepin, Stephanie
    Syrjaenen, Ritva K.
    Mari, Karine
    Mallett Moore, Tamala
    Jokinen, Jukka
    Nieminen, Heta
    Kilpi, Terhi
    Samson, Sandrine I.
    De Bruijn, Iris
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (04)
  • [33] Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study
    Chen, Jau-Yuan
    Hsieh, Szu-Min
    Hwang, Shinn-Jang
    Liu, Chiu-Shong
    Li, Xiaoling
    Fournier, Marion
    Yeh, Ting-Yu
    Yin, J. Kevin
    Samson, Sandrine, I
    VACCINE, 2022, 40 (45) : 6450 - 6454
  • [34] Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
    Nham, Eliel
    Seong, Hye
    Hyun, Hakjun
    Yoon, Jin Gu
    Noh, Ji Yun
    Cheong, Hee Jin
    Kim, Woo Joo
    Kim, Eugene
    Choi, Leejung
    Lee, Jung-Min
    Song, Joon Young
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [35] New high-dose Birch Preparation
    不详
    ALLERGO JOURNAL, 2009, 18 (01) : 81 - 81
  • [36] Fluzone® High-Dose Influenza Vaccine with a Booster Is Associated with Low Rates of Influenza Infection in Patients with Plasma Cell Disorders
    Branagan, Andrew R.
    Duffy, Eamon
    Boddupall, Chandra Sekhar
    Albrecht, Randy A.
    Zhang, Lin
    Verma, Rakesh
    Cooper, Dennis L.
    Seropian, Stuart
    Parker, Terri L.
    Yao, Xiaopan
    Ferencz, Thomas M.
    Dhodapkar, Madhav V.
    BLOOD, 2015, 126 (23)
  • [37] Reply letter to "Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial"
    Hadigal, Sanjay
    Colombo, Laura
    Haughie, Scott
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [38] SAFETY AND RECOVERY OF MONONINE IN MULTIPLE-DOSE, HIGH-DOSE REGIMENS
    WHITE, GC
    ACTA HAEMATOLOGICA, 1995, 94 : 53 - 58
  • [39] Safety of high-dose micafungin for patients with hematological diseases
    Yamazaki, Sho
    Nakamura, Fumihiko
    Yoshimi, Akihide
    Ichikawa, Motoshi
    Nannya, Yasuhito
    Kurokawa, Mineo
    LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2572 - 2576
  • [40] Safety of high-dose intravenous labetalol in hypertensive crisis
    Hecht, Jason P.
    Mahmood, Syeda M.
    Brandt, Mary-Margaret
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (05) : 286 - 292
12345